Welcome to This Week in Ophthalmology. This week we're covering 10 notable papers spanning major advances in glaucoma surgery, the expanding role of artificial intelligence in diagnostics, and new guidance on several pressing clinical challenges. Let's dive in.

This week's papers:

1. Outcomes of minimally invasive glaucoma surgery, trabeculectomy, and tube shunt surgery in secondary glaucoma: IRIS® Registry analysis. — American journal of ophthalmology 2026
2. Analysis of choroidal OCT intensity and profile changes in high myopia: correlation with visual impairment and identification of pathological myopia. — The British journal of ophthalmology 2026
3. Multimodal artificial intelligence in retinopathy of prematurity: A comprehensive narrative review. — Survey of ophthalmology 2026
4. Intravitreal Bevacizumab Improves Trabeculectomy Survival at 3 Years: Long-term Follow-up from The 'Bevacizumab in Trabeculectomy Study'. — Ophthalmology 2026
5. Improving Efficiency in Geographic Atrophy Clinical Trials Using Run-In Phases or Single-Arm Designs. — JAMA ophthalmology 2026
6. Generative Artificial Intelligence-Driven Voice Assistance for Patient Education in Ophthalmology. — JAMA ophthalmology 2026
7. Small Copy Number Neutral Intrachromosomal Translocation of PAX6 and Aniridia. — JAMA ophthalmology 2026
8. Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology. — Ophthalmology 2026
9. Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion. — The British journal of ophthalmology 2026
10. Peripheral retinal haemorrhage density on ultra-widefield imaging as a novel biomarker for predicting diabetic retinopathy progression: a 2-year longitudinal study in Asians. — The British journal of ophthalmology 2026

Listen at AudioScholar